Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ocugen, Inc. Director's Dealing 2016

Dec 2, 2016

32915_dirs_2016-12-02_71d2c5ec-95e8-4054-aac7-7fc7fbe98d70.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2016-11-30

Reporting Person: RAKIN KEVIN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-30 Common Stock C 26699 Acquired 112499 Indirect
2016-11-30 Common Stock C 26699 Acquired 139198 Indirect
2016-11-30 Common Stock C 88998 Acquired 228196 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-30 Series A Convertible Preferred Stock $ C 60.0728 Disposed Common Stock (26699) Indirect
2016-11-30 Series A Convertible Preferred Stock $ C 60.0728 Disposed Common Stock (26699) Indirect
2016-11-30 Series A Convertible Preferred Stock $ C 200.2455 Disposed Common Stock (88998) Indirect

Footnotes

F1: All outstanding shares of the Issuer's Series A Convertible Preferred Stock converted on a 1:444.444444 basis into shares of the Issuer's Common Stock. These shares have no expiration date.

F2: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Sarah Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose, except to the extent of his pecuniary interest therein.

F3: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Julia Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.

F4: The reportable securities are owned by the Kevin L Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.